Register for real-time alerts, custom portfolio, and market movers
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| XBiotech Inc | XBIT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.23 | 2.89% | 8.18 | 18:07:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.75 | 7.75 | 8.55 | 8.18 | 7.95 |
Recent News
| Date | Time | Source | Heading |
|---|---|---|---|
| 2/07/2024 | 12:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/07/2024 | 12:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/05/2024 | 10:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/04/2024 | 09:00 | EDGAR2 | Form 8-K - Current report |
| 1/04/2024 | 09:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
| 11/14/2023 | 09:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
| 11/09/2023 | 14:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 9/26/2023 | 09:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
| 8/30/2023 | 09:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
| 8/11/2023 | 11:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/08/2023 | 11:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
| 5/22/2023 | 09:00 | GLOBE | FDA Authorizes Phase II Study for Natrunix in Rheumatoid.. |
| 5/17/2023 | 09:00 | GLOBE | XBiotech Commences Tender Offer to Purchase up to.. |
